These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33246418)

  • 1. An aggressive systemic mastocytosis preceded by ovarian dysgerminoma.
    Tsutsumi M; Miura H; Inagaki H; Shinkai Y; Kato A; Kato T; Hamada-Tsutsumi S; Tanaka M; Kudo K; Yoshikawa T; Kurahashi H
    BMC Cancer; 2020 Nov; 20(1):1162. PubMed ID: 33246418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia.
    Mitchell SG; Bunting ST; Saxe D; Olson T; Keller FG
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian germ cell tumor/mastocytosis with KIT mutation: A unique clinicopathological entity.
    Xiao P; Chen P; Lang X; An Q; Yang C; Chen S; Wang K; Chen N; Hao Y; Ding J; Li Z; Hu S; Xiao S
    Genes Chromosomes Cancer; 2022 Jan; 61(1):50-54. PubMed ID: 34553465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states.
    Lee JW; Yang WS; Chung SY; Kang JH; Cho B; Kim HK; Kim KM; Jeong DC
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):412-5. PubMed ID: 17551405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy 21 associated with ovarian dysgerminoma.
    Smucker JD; Roth LM; Sutton GP; Hurteau JA
    Gynecol Oncol; 1999 Sep; 74(3):512-4. PubMed ID: 10479522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ cell tumors of the ovary: the role of pathology in diagnosis and management.
    Jimerson GK
    Clin Obstet Gynecol; 1974 Mar; 17(1):229-39. PubMed ID: 4363500
    [No Abstract]   [Full Text] [Related]  

  • 9. Paraneoplastic Cholestasis Associated With Ovarian Dysgerminoma.
    Yeh KE; Marcus PS; Fong TL
    Obstet Gynecol; 2015 Aug; 126(2):431-434. PubMed ID: 25923022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy in association with an ovarian dysgerminoma.
    Ivanaj A; Pautier P; Rixe O; Duvillard P; Dubard T
    Gynecol Oncol; 2003 Apr; 89(1):168-70. PubMed ID: 12694672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotoxicosis induced by choriocarcinoma a report of two cases.
    O'Reilly S; Lyons DJ; Harrison M; Gaffney E; Cullen M; Clancy L
    Ir Med J; 1993; 86(4):124, 127. PubMed ID: 8395487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed ovarian germ cell tumor in a BRCA2 mutation carrier.
    Hamel N; Wong N; Alpert L; Galvez M; Foulkes WD
    Int J Gynecol Pathol; 2007 Apr; 26(2):160-4. PubMed ID: 17413983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
    Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anatamo-pathological aspects of malignant ovarian tumors in children. Apropos of 16 cases].
    Makni MK; Mzabi-Regaya S; Kattech A; Chadli A
    Arch Inst Pasteur Tunis; 1988; 65(1-2):87-98. PubMed ID: 2845875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant ovarian germ cell tumors. Current status of diagnosis and treatment].
    Torres-Lobatón A
    Ginecol Obstet Mex; 2014 Mar; 82(3):177-87. PubMed ID: 24779273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysgerminoma of the ovary in a patient with triple-X syndrome.
    Kemp B; Hauptmann S; Schröder W; Amo-Takyi B; Leeners B; Rath W
    Int J Gynaecol Obstet; 1995 Jul; 50(1):51-3. PubMed ID: 7556861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late relapse of ovarian dysgerminoma: case report and literature review.
    Bekaii-Saab T; Einhorn LH; Williams SD
    Gynecol Oncol; 1999 Jan; 72(1):111-2. PubMed ID: 9889041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
    Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
    Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon Metastasis of Ovarian Dysgerminoma: A Case Report and Review of the Literature.
    Tîrnovanu MC; Florea ID; Tănase A; Toma BF; Cojocaru E; Ungureanu C; Lozneanu L
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34071828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ Cell Tumors of the Female Genital Tract.
    Euscher ED
    Surg Pathol Clin; 2019 Jun; 12(2):621-649. PubMed ID: 31097117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.